Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05181826 | RECRUITING | Cancer

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Sponsor:

Helio Genomics

Brief Summary:

To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.

Condition or disease

Cancer

Liver Cirrhosis

Chronic Hepatitis

Hepatitis B

Hepatitis C

Diabetes

COPD

Intervention/treatment

Multi-analyte Blood Test

Detailed Description:

Whole blood, plasma, and/or serum specimens will be collected from patients with active cancer, patients in cancer remission, patients diagnosed with benign disease, and healthy volunteers. These blood samples will be used to perform various studies to determine the utility of select DNA methylation markers for cancer diagnostic or prognostic indications.

Study Type : OBSERVATIONAL
Estimated Enrollment : 1200 participants
Official Title : Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Actual Study Start Date : 2019-05-21
Estimated Primary Completion Date : 2025-09
Estimated Study Completion Date : 2025-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Criteria
Inclusion Criteria
  • 2.1.1 Age 18 years or older.
  • 2.1.2 A diagnosis of cancer, cancer remission, benign disease (benign tumor, diabetes, liver cirrhosis, chronic hepatitis B or hepatitis C virus infection, Chronic obstructive pulmonary disease, etc.) or apparently healthy volunteers. .
Exclusion Criteria
  • 2.2.1 Patients that are unwilling or unable to sign the Informed Consent Form will be excluded.
  • 2.2.2 Approximately 50 mL of blood will be drawn from participants within an 8-week period under this protocol. Patients that have already given 50 mL of blood within this time frame will be excluded.
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Location Details

NCT05181826

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

ACTIVE NOT RECRUITING

United States, California

Torrance Memorial Physician Network - Cancer Care

Redondo Beach, California, United States, 90277

RECRUITING

United States, Minnesota

Allina Health, Virginia Piper Cancer Institute

Coon Rapids, Minnesota, United States, 55433

RECRUITING

United States, Minnesota

Virginia Piper Cancer Institute Mercy Hospital-Unity Campus

Fridley, Minnesota, United States, 55432

RECRUITING

United States, Minnesota

VPCI Oncology Research

Minneapolis, Minnesota, United States, 55407

RECRUITING

United States, Tennessee

Methodist LeBonheur Healthcare

Memphis, Tennessee, United States, 38104

RECRUITING

United States, Texas

Liver Center of Texas

dallas, Texas, United States, 75234

RECRUITING

United States, Texas

Methodist Hospital

Richardson, Texas, United States, 75082